All of our results feed back into our drug discovery and drug development platform – the Recursion Operating System – in a continuously improving feedback loop.

Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high unmet need, …

Embark on a career journey with Recursion. Dive into opportunities, culture, and the impact you can make. Apply to work with us today!

Sep 1, 2017 · Stay updated with the latest press releases and news from Recursion. Dive into our achievements, announcements, and more. Explore now!

Nov 5, 2013 · We are not here to make a few medicines. We are here to reimagine how medicines are made. The Recursion mindset is the deep belief and commitment to industrializing drug discovery …

Unlike traditional drug discovery, which begins with a specific target or hypothesis, we leverage the Recursion OS — our drug discovery and development platform for AI in pharma connects technical …

Erica joined Recursion from Primer.ai, where she served as Chief People Officer. Prior to Primer, Erica spent 15 years at Google leading and contributing to major people and culture initiatives that enabled …

Ben Taylor comes to Recursion after over 4 years as the CFO of Exscientia. Ben has more than two decades of experience in healthcare investment banking and executive roles, including 15 years at …

Delve into Recursion's unique TechBio approach. Discover how we're revolutionizing drug discovery and biotech. Read moer about our approach today!

Dave Hallett comes to Recursion after approximately 5 years as the Chief Scientific Officer and Interim CEO of Exscientia. David Hallett, Ph.D., is an experienced “drug hunter” with over 20 years’ track …